Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: Preliminary experience

Radiology

Volumn 207, Issue 2, 1998, Pages 339-347

  Albrecht, Thomas ^a,c   Urbank, Albrecht ^b   Mahler, Marianne ^b   Bauer, Albrecht ^b   Doré, Caroline J ^a   Blomley, Martin J K ^a   Cosgrove, David O ^a   Schlief, Reinhard ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Dept of Clin Devmt Diagnostics ^*  (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Arteries, femoral; Arteries, US; Carotid arteries, US; Microbubbles; Ultrasound (US), contrast media; Ultrasound (US), Doppler studies

Indexed keywords

ECHO CONTRAST MEDIUM; SHU 508;

ADULT; ARTICLE; BOLUS INJECTION; CAROTID ARTERY; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMORAL ARTERY; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

EID: 0031836462     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.207.2.9577478     Document Type: Article

References (14)

1. Von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide based transpulmonary contrast agent: the Levovist cardiac working group. J Am Coll Cardiol 1995; 25:500-508.
2. Bauer A, Becker G, Krone A, Fröhlich T, Bogdahn U. Transcranial duplex sonography using ultrasound contrast agents. Clin Radiol 1996; 51(suppl):19-23.
3. Langholz J, Schlief R, Schürmann R, Wanke M, Heidrich H. Contrast enhancement in leg vessels. Clin Radiol 1996; 51(suppl): 31-34.
4. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses - work in progress. Radiology 1996; 198:679-686.
5. Schwarz K, Bezante GP, Chen X, Schlief R. Quantitative echo-contrast concentration measurement by Doppler sonography. Ultrasound Med Biol 1993; 4:289-297.
6. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
7. Fleiss JL. The design and analysis of clinical experiments. New York, NY: Wiley, 1986; 3, 28.
8. Albrecht T, Cosgrove DO, Correas JM, Rallidis L, Nihoyannopoulos P, Patel N. Renal, hepatic, and cardiac enhancement on Doppler and gray scale sonograms obtained with EchoGen. Acad Radiol 1996; 3(suppl):S198-S203.
9. Blomley M, Jayaram V, Cosgrove DO, Patel N, Albrecht T, Lull J. Doppler intensitometry with BR1 in humans: a linear dose response relationship (abstr). Radiology 1996; 201(P):158.
10. Unger EC, Fritz TA. Phase I and II clinical trials of MRX-115, a new US contrast agent (abstr). Radiology 1996; 201(P):158.
11. Mattrey RF, Manspeaker P, Pelura TJ, Batra S, Leese PT. Safety and preliminary efficacy of AF0150: phase I clinical trial in healthy volunteers (abstr). Radiology 1996; 201(P):158.
12. Foley WD, Quiroz FA, Papke RA. Analysis of dwell time with use of Dodecaflouropentane, a US contrast agent (abstr). Radiology 1996; 201(P):159.
13. Bell DS, Bamber JC, Eckersley RJ. Segmentation and analysis of colour Doppler images of tumour vasculature. Ultrasound Med Biol 1995; 21:635-647.
14. Blomley MJ, Cosgrove DO, Albrecht T, Powers JE, Urbank A. Quantification of microbubble concentration by using color power Doppler US (abstr). Radiology 1996; 201(P):159.